Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Adverse cardiovascular, limb, and renal outcomes in patients with diabetes after peripheral artery disease revascularization treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors

Fig. 2

Cumulative incidence curves of cardiovascular outcomes for SGLT2i versus DPP4i (after PSM) among patients with T2D who had undergone PAD revascularization. Cumulative incidence curves of specified outcomes of SGLT2i versus DPP4i (after PSM) among patients with T2D who had undergone PAD revascularization: (A) IS, (B) AMI, (C) HFH, and (D) cardiac death are presented. SGLT2i were associated with comparable cumulative risks of IS, AMI, and HFH and a lower cumulative risk of cardiac death compared with DPP4i. AMI acute myocardial infarction, HFH heart failure hospitalization, IS ischemic stroke, PSM propensity score matching. Other abbreviations are the same as those in Fig. 1

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us